+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Pigmentation Disorder Treatment Market Size, Share & Industry Trends Analysis Report By Type (Vitiligo, Melasma), By Treatment (Corticosteroids, Calcineurin Inhibitor, and Others), By Distribution Channel, By Regional Outlook and Forecast, 2023 - 2030

  • PDF Icon

    Report

  • 238 Pages
  • September 2023
  • Region: Global
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5903281
Description Jump to:
The Global Pigmentation Disorder Treatment Market size is expected to reach $1.2 billion by 2030, rising at a market growth of 4.8% CAGR during the forecast period.

There has been a significant increase in awareness regarding pigmentation disorders, skin health, and skincare in the APAC region. Consequently, the APAC region registered $212.6 million revenue in the market in 2022. People are becoming more conscious of their skin's appearance and health, increasing their willingness to seek treatment for pigmentation issues. Rapid urbanization in many APAC countries has brought changes in lifestyle and exposure to environmental factors that can exacerbate pigmentation disorders. Urban populations often have more access to healthcare facilities, including dermatologists. APAC countries often experience high levels of sunlight, which can contribute to pigmentation disorders such as melasma and solar lentigines. This has prompted people to seek treatments like sunscreens and laser therapy. Some of the factors impacting the market are growing awareness of skin health, advancements in treatment modalities, and limited efficacy of currently available treatments.



Greater awareness of the importance of skin health and aesthetics has prompted more individuals to seek treatment for pigmentation issues. People are becoming more proactive about addressing skin concerns. As individuals become more informed about skin health, they are more likely to recognize the early signs of pigmentation disorders. This can lead to earlier diagnosis and intervention, potentially improving treatment outcomes. Advances in dermatological treatments have improved the effectiveness and safety of pigmentation disorder treatments. Innovative technologies offer better outcomes, such as laser therapy, chemical peels, microneedling, and topical formulations. Advancements in treatment modalities often result in more effective treatments in addressing pigmentation disorders. For example, newer laser technologies and techniques can target pigmentation with greater precision, leading to improved outcomes. Thus, the advancements in treatment modalities benefit patients by providing more effective and comfortable treatment options and driving growth in the market.

However, the limited efficacy of currently available pigmentation disorder treatment options is a significant concern in the field of dermatology. One of the primary factors contributing to this limitation is the complex and multifaceted nature of these conditions. Pigmentation disorders often involve intricate mechanisms within the skin, making them resistant to straightforward treatment approaches. As a result, there is no one-size-fits-all solution, and the quest for effective treatments continues to challenge dermatologists and researchers. Moreover, the pandemic disrupted global supply chains, including skin care products and dermatological equipment production and distribution. This led to shortages of certain treatment products and delayed the availability of new treatments. Economic uncertainties caused by the pandemic led some individuals to reduce discretionary spending, including spending on cosmetic and dermatological treatments. This economic impact affected the affordability and demand for pigmentation disorder treatments.

Distribution Channel Outlook

On the basis of distribution channel, the market is divided into hospital pharmacies, drug store & retail pharmacies, and online pharmacies. The drug store and retail pharmacies segment recorded the maximum revenue share in the market in 2022. Drug stores and retail pharmacies typically offer a range of OTC skincare products, including those designed for pigmentation disorders. This increased accessibility allows individuals to explore and try certain treatments without a prescription, potentially boosting sales of these products. Many prescription pigmentation disorder treatments, such as topical corticosteroids, calcineurin inhibitors, and specialized creams, can be dispensed by retail pharmacies.

Type Outlook

By type, the market is categorized into vitiligo, melasma, and others. In 2022, the vitiligo segment held the highest revenue share in the market. Vitiligo is a specific pigmentation disorder characterized by the loss of melanocytes (pigment-producing cells) in certain areas of the skin, resulting in the development of white patches. The treatment of vitiligo is a significant component of the broader market. Topical corticosteroids, calcineurin inhibitors, and topical calcipotriene commonly treat vitiligo. These products are directly applied to the afflicted areas of the skin to reduce inflammation and encourage repigmentation. They are an essential part of the market.

Treatment Outlook

Based on treatment, the market is segmented into corticosteroids, calcineurin inhibitor, and others. The calcineurin inhibitor segment garnered a significant revenue share in the market in 2022. Calcineurin inhibitors have effectively treated pigmentation disorders like vitiligo, particularly in areas where corticosteroids may be less suitable due to skin thinning or other concerns. These medications work by modulating the immune response in the skin, which can be particularly useful for pigmentation disorders with autoimmune or inflammatory components. Calcineurin inhibitors are generally considered safe for long-term use on delicate or sensitive skin areas, such as the face and genital area, where corticosteroids might carry a higher risk of side effects.

Regional Outlook

Region-wise, the market is analyzed across North America, Europe, Asia Pacific, and LAMEA. In 2022, the North America region led the market by generating the highest revenue share. Dermatological clinics and medical spas are key providers of pigmentation disorder treatments in North America. These facilities offered various services, including consultations, in-office procedures, and skincare products. The well-established healthcare infrastructure in North America, including many dermatology clinics and well-trained dermatologists, supported the market's growth. Advancements in laser technology and innovative treatment devices enhanced the efficacy and safety of pigmentation disorder treatments in North America.

The market research report covers the analysis of key stakeholders of the market. Key companies profiled in the report include Bausch Health Companies Inc, Glenmark Pharmaceuticals Limited, Obagi Cosmeceuticals LLC, AbbVie, Inc., Dermavant Sciences, Inc. (Roivant Sciences Ltd.), Incyte Corporation, Dr. Reddy’s Laboratories Ltd., Galderma S.A., Viatris, Inc. (Mylan N.V.), and Pfizer, Inc.

Scope of the Study

Market Segments Covered in the Report:

By Type
  • Vitiligo
  • Melasma
  • Others
By Treatment
  • Corticosteroids
  • Calcineurin Inhibitor
  • Others
By Distribution Channel
  • Drug Store & Retail Pharmacies
  • Hospital Pharmacies
  • Online Pharmacies
By Geography
  • North America
  • US
  • Canada
  • Mexico
  • Rest of North America
  • Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
  • LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Key Market Players

List of Companies Profiled in the Report:

  • Bausch Health Companies Inc
  • Glenmark Pharmaceuticals Limited
  • Obagi Cosmeceuticals LLC
  • AbbVie, Inc.
  • Dermavant Sciences, Inc. (Roivant Sciences Ltd.)
  • Incyte Corporation
  • Dr.Reddy’s Laboratories Ltd.
  • Galderma S.A.
  • Viatris, Inc. (Mylan N.V.)
  • Pfizer, Inc.

Unique Offerings

  • Exhaustive coverage
  • The highest number of Market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Pigmentation Disorder Treatment Market, by Type
1.4.2 Global Pigmentation Disorder Treatment Market, by Treatment
1.4.3 Global Pigmentation Disorder Treatment Market, by Distribution Channel
1.4.4 Global Pigmentation Disorder Treatment Market, by Geography
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.3 Porter Five Forces Analysis
Chapter 4. Global Pigmentation Disorder Treatment Market, By Type
4.1 Global Vitiligo Market, By Region
4.2 Global Melasma Market, By Region
4.3 Global Others Market, By Region
Chapter 5. Global Pigmentation Disorder Treatment Market, By Treatment
5.1 Global Corticosteroids Market, By Region
5.2 Global Calcineurin Inhibitor Market, By Region
5.3 Global Others Market, By Region
Chapter 6. Global Pigmentation Disorder Treatment Market, By Distribution Channel
6.1 Global Drug Store & Retail Pharmacies Market, By Region
6.2 Global Hospital Pharmacies Market, By Region
6.3 Global Online Pharmacies Market, By Region
Chapter 7. Global Pigmentation Disorder Treatment Market, By Region
7.1 North America Pigmentation Disorder Treatment Market
7.1.1 North America Pigmentation Disorder Treatment Market, By Type
7.1.1.1 North America Vitiligo Market, By Country
7.1.1.2 North America Melasma Market, By Country
7.1.1.3 North America Others Market, By Country
7.1.2 North America Pigmentation Disorder Treatment Market, By Treatment
7.1.2.1 North America Corticosteroids Market, By Country
7.1.2.2 North America Calcineurin Inhibitor Market, By Country
7.1.2.3 North America Others Market, By Country
7.1.3 North America Pigmentation Disorder Treatment Market, By Distribution Channel
7.1.3.1 North America Drug Store & Retail Pharmacies Market, By Country
7.1.3.2 North America Hospital Pharmacies Market, By Country
7.1.3.3 North America Online Pharmacies Market, By Country
7.1.4 North America Pigmentation Disorder Treatment Market, By Country
7.1.4.1 US Pigmentation Disorder Treatment Market
7.1.4.1.1 US Pigmentation Disorder Treatment Market, By Type
7.1.4.1.2 US Pigmentation Disorder Treatment Market, By Treatment
7.1.4.1.3 US Pigmentation Disorder Treatment Market, By Distribution Channel
7.1.4.2 Canada Pigmentation Disorder Treatment Market
7.1.4.2.1 Canada Pigmentation Disorder Treatment Market, By Type
7.1.4.2.2 Canada Pigmentation Disorder Treatment Market, By Treatment
7.1.4.2.3 Canada Pigmentation Disorder Treatment Market, By Distribution Channel
7.1.4.3 Mexico Pigmentation Disorder Treatment Market
7.1.4.3.1 Mexico Pigmentation Disorder Treatment Market, By Type
7.1.4.3.2 Mexico Pigmentation Disorder Treatment Market, By Treatment
7.1.4.3.3 Mexico Pigmentation Disorder Treatment Market, By Distribution Channel
7.1.4.4 Rest of North America Pigmentation Disorder Treatment Market
7.1.4.4.1 Rest of North America Pigmentation Disorder Treatment Market, By Type
7.1.4.4.2 Rest of North America Pigmentation Disorder Treatment Market, By Treatment
7.1.4.4.3 Rest of North America Pigmentation Disorder Treatment Market, By Distribution Channel
7.2 Europe Pigmentation Disorder Treatment Market
7.2.1 Europe Pigmentation Disorder Treatment Market, By Type
7.2.1.1 Europe Vitiligo Market, By Country
7.2.1.2 Europe Melasma Market, By Country
7.2.1.3 Europe Others Market, By Country
7.2.2 Europe Pigmentation Disorder Treatment Market, By Treatment
7.2.2.1 Europe Corticosteroids Market, By Country
7.2.2.2 Europe Calcineurin Inhibitor Market, By Country
7.2.2.3 Europe Others Market, By Country
7.2.3 Europe Pigmentation Disorder Treatment Market, By Distribution Channel
7.2.3.1 Europe Drug Store & Retail Pharmacies Market, By Country
7.2.3.2 Europe Hospital Pharmacies Market, By Country
7.2.3.3 Europe Online Pharmacies Market, By Country
7.2.4 Europe Pigmentation Disorder Treatment Market, By Country
7.2.4.1 Germany Pigmentation Disorder Treatment Market
7.2.4.1.1 Germany Pigmentation Disorder Treatment Market, By Type
7.2.4.1.2 Germany Pigmentation Disorder Treatment Market, By Treatment
7.2.4.1.3 Germany Pigmentation Disorder Treatment Market, By Distribution Channel
7.2.4.2 UK Pigmentation Disorder Treatment Market
7.2.4.2.1 UK Pigmentation Disorder Treatment Market, By Type
7.2.4.2.2 UK Pigmentation Disorder Treatment Market, By Treatment
7.2.4.2.3 UK Pigmentation Disorder Treatment Market, By Distribution Channel
7.2.4.3 France Pigmentation Disorder Treatment Market
7.2.4.3.1 France Pigmentation Disorder Treatment Market, By Type
7.2.4.3.2 France Pigmentation Disorder Treatment Market, By Treatment
7.2.4.3.3 France Pigmentation Disorder Treatment Market, By Distribution Channel
7.2.4.4 Russia Pigmentation Disorder Treatment Market
7.2.4.4.1 Russia Pigmentation Disorder Treatment Market, By Type
7.2.4.4.2 Russia Pigmentation Disorder Treatment Market, By Treatment
7.2.4.4.3 Russia Pigmentation Disorder Treatment Market, By Distribution Channel
7.2.4.5 Spain Pigmentation Disorder Treatment Market
7.2.4.5.1 Spain Pigmentation Disorder Treatment Market, By Type
7.2.4.5.2 Spain Pigmentation Disorder Treatment Market, By Treatment
7.2.4.5.3 Spain Pigmentation Disorder Treatment Market, By Distribution Channel
7.2.4.6 Italy Pigmentation Disorder Treatment Market
7.2.4.6.1 Italy Pigmentation Disorder Treatment Market, By Type
7.2.4.6.2 Italy Pigmentation Disorder Treatment Market, By Treatment
7.2.4.6.3 Italy Pigmentation Disorder Treatment Market, By Distribution Channel
7.2.4.7 Rest of Europe Pigmentation Disorder Treatment Market
7.2.4.7.1 Rest of Europe Pigmentation Disorder Treatment Market, By Type
7.2.4.7.2 Rest of Europe Pigmentation Disorder Treatment Market, By Treatment
7.2.4.7.3 Rest of Europe Pigmentation Disorder Treatment Market, By Distribution Channel
7.3 Asia Pacific Pigmentation Disorder Treatment Market
7.3.1 Asia Pacific Pigmentation Disorder Treatment Market, By Type
7.3.1.1 Asia Pacific Vitiligo Market, By Country
7.3.1.2 Asia Pacific Melasma Market, By Country
7.3.1.3 Asia Pacific Others Market, By Country
7.3.2 Asia Pacific Pigmentation Disorder Treatment Market, By Treatment
7.3.2.1 Asia Pacific Corticosteroids Market, By Country
7.3.2.2 Asia Pacific Calcineurin Inhibitor Market, By Country
7.3.2.3 Asia Pacific Others Market, By Country
7.3.3 Asia Pacific Pigmentation Disorder Treatment Market, By Distribution Channel
7.3.3.1 Asia Pacific Drug Store & Retail Pharmacies Market, By Country
7.3.3.2 Asia Pacific Hospital Pharmacies Market, By Country
7.3.3.3 Asia Pacific Online Pharmacies Market, By Country
7.3.4 Asia Pacific Pigmentation Disorder Treatment Market, By Country
7.3.4.1 China Pigmentation Disorder Treatment Market
7.3.4.1.1 China Pigmentation Disorder Treatment Market, By Type
7.3.4.1.2 China Pigmentation Disorder Treatment Market, By Treatment
7.3.4.1.3 China Pigmentation Disorder Treatment Market, By Distribution Channel
7.3.4.2 Japan Pigmentation Disorder Treatment Market
7.3.4.2.1 Japan Pigmentation Disorder Treatment Market, By Type
7.3.4.2.2 Japan Pigmentation Disorder Treatment Market, By Treatment
7.3.4.2.3 Japan Pigmentation Disorder Treatment Market, By Distribution Channel
7.3.4.3 India Pigmentation Disorder Treatment Market
7.3.4.3.1 India Pigmentation Disorder Treatment Market, By Type
7.3.4.3.2 India Pigmentation Disorder Treatment Market, By Treatment
7.3.4.3.3 India Pigmentation Disorder Treatment Market, By Distribution Channel
7.3.4.4 South Korea Pigmentation Disorder Treatment Market
7.3.4.4.1 South Korea Pigmentation Disorder Treatment Market, By Type
7.3.4.4.2 South Korea Pigmentation Disorder Treatment Market, By Treatment
7.3.4.4.3 South Korea Pigmentation Disorder Treatment Market, By Distribution Channel
7.3.4.5 Singapore Pigmentation Disorder Treatment Market
7.3.4.5.1 Singapore Pigmentation Disorder Treatment Market, By Type
7.3.4.5.2 Singapore Pigmentation Disorder Treatment Market, By Treatment
7.3.4.5.3 Singapore Pigmentation Disorder Treatment Market, By Distribution Channel
7.3.4.6 Malaysia Pigmentation Disorder Treatment Market
7.3.4.6.1 Malaysia Pigmentation Disorder Treatment Market, By Type
7.3.4.6.2 Malaysia Pigmentation Disorder Treatment Market, By Treatment
7.3.4.6.3 Malaysia Pigmentation Disorder Treatment Market, By Distribution Channel
7.3.4.7 Rest of Asia Pacific Pigmentation Disorder Treatment Market
7.3.4.7.1 Rest of Asia Pacific Pigmentation Disorder Treatment Market, By Type
7.3.4.7.2 Rest of Asia Pacific Pigmentation Disorder Treatment Market, By Treatment
7.3.4.7.3 Rest of Asia Pacific Pigmentation Disorder Treatment Market, By Distribution Channel
7.4 LAMEA Pigmentation Disorder Treatment Market
7.4.1 LAMEA Pigmentation Disorder Treatment Market, By Type
7.4.1.1 LAMEA Vitiligo Market, By Country
7.4.1.2 LAMEA Melasma Market, By Country
7.4.1.3 LAMEA Others Market, By Country
7.4.2 LAMEA Pigmentation Disorder Treatment Market, By Treatment
7.4.2.1 LAMEA Corticosteroids Market, By Country
7.4.2.2 LAMEA Calcineurin Inhibitor Market, By Country
7.4.2.3 LAMEA Others Market, By Country
7.4.3 LAMEA Pigmentation Disorder Treatment Market, By Distribution Channel
7.4.3.1 LAMEA Drug Store & Retail Pharmacies Market, By Country
7.4.3.2 LAMEA Hospital Pharmacies Market, By Country
7.4.3.3 LAMEA Online Pharmacies Market, By Country
7.4.4 LAMEA Pigmentation Disorder Treatment Market, By Country
7.4.4.1 Brazil Pigmentation Disorder Treatment Market
7.4.4.1.1 Brazil Pigmentation Disorder Treatment Market, By Type
7.4.4.1.2 Brazil Pigmentation Disorder Treatment Market, By Treatment
7.4.4.1.3 Brazil Pigmentation Disorder Treatment Market, By Distribution Channel
7.4.4.2 Argentina Pigmentation Disorder Treatment Market
7.4.4.2.1 Argentina Pigmentation Disorder Treatment Market, By Type
7.4.4.2.2 Argentina Pigmentation Disorder Treatment Market, By Treatment
7.4.4.2.3 Argentina Pigmentation Disorder Treatment Market, By Distribution Channel
7.4.4.3 UAE Pigmentation Disorder Treatment Market
7.4.4.3.1 UAE Pigmentation Disorder Treatment Market, By Type
7.4.4.3.2 UAE Pigmentation Disorder Treatment Market, By Treatment
7.4.4.3.3 UAE Pigmentation Disorder Treatment Market, By Distribution Channel
7.4.4.4 Saudi Arabia Pigmentation Disorder Treatment Market
7.4.4.4.1 Saudi Arabia Pigmentation Disorder Treatment Market, By Type
7.4.4.4.2 Saudi Arabia Pigmentation Disorder Treatment Market, By Treatment
7.4.4.4.3 Saudi Arabia Pigmentation Disorder Treatment Market, By Distribution Channel
7.4.4.5 South Africa Pigmentation Disorder Treatment Market
7.4.4.5.1 South Africa Pigmentation Disorder Treatment Market, By Type
7.4.4.5.2 South Africa Pigmentation Disorder Treatment Market, By Treatment
7.4.4.5.3 South Africa Pigmentation Disorder Treatment Market, By Distribution Channel
7.4.4.6 Nigeria Pigmentation Disorder Treatment Market
7.4.4.6.1 Nigeria Pigmentation Disorder Treatment Market, By Type
7.4.4.6.2 Nigeria Pigmentation Disorder Treatment Market, By Treatment
7.4.4.6.3 Nigeria Pigmentation Disorder Treatment Market, By Distribution Channel
7.4.4.7 Rest of LAMEA Pigmentation Disorder Treatment Market
7.4.4.7.1 Rest of LAMEA Pigmentation Disorder Treatment Market, By Type
7.4.4.7.2 Rest of LAMEA Pigmentation Disorder Treatment Market, By Treatment
7.4.4.7.3 Rest of LAMEA Pigmentation Disorder Treatment Market, By Distribution Channel
Chapter 8. Company Profiles
8.1 Bausch Health Companies Inc
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expenses
8.1.5 SWOT Analysis
8.2 Glenmark Pharmaceuticals Limited
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Regional Analysis
8.2.4 Research & Development Expenses
8.2.5 SWOT Analysis
8.3 Obagi Cosmeceuticals LLC
8.3.1 Company Overview
8.3.2 SWOT Analysis
8.4 AbbVie, Inc.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Regional Analysis
8.4.4 Research & Development Expense
8.5 Dermavant Sciences, Inc. (Roivant Sciences Ltd.)
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Research & Development Expenses
8.5.4 SWOT Analysis
8.6 Incyte Corporation
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Research & Development Expenses
8.6.3.1 Acquisition and Mergers:
8.6.3.2 Trials and Approvals:
8.6.4 SWOT Analysis
8.7 Dr. Reddy’s Laboratories Ltd.
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expense
8.7.5 SWOT Analysis
8.8 Galderma S.A.
8.8.1 Company Overview
8.9 Viatris, Inc. (Mylan N.V.)
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Segmental Analysis
8.9.4 Research & Development Expense
8.9.5 SWOT Analysis
8.10. Pfizer, Inc.
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Regional & Segmental Analysis
8.10.4 Research & Development Expense
8.10.5 SWOT Analysis
Chapter 9. Winning imperatives of Pigmentation Disorder Treatment Market

Companies Mentioned

  • Bausch Health Companies Inc
  • Glenmark Pharmaceuticals Limited
  • Obagi Cosmeceuticals LLC
  • AbbVie, Inc.
  • Dermavant Sciences, Inc. (Roivant Sciences Ltd.)
  • Incyte Corporation
  • Dr. Reddy’s Laboratories Ltd.
  • Galderma S.A.
  • Viatris, Inc. (Mylan N.V.)
  • Pfizer, Inc.

Methodology

Loading
LOADING...

Related Topics

Related Reports

Pigmentation Disorders Treatment Global Market Report 2024 - Product Image

Pigmentation Disorders Treatment Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Pigmentation Disorders Treatment - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2021 - 2029 - Product Image

Pigmentation Disorders Treatment - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2021 - 2029

  • Report
  • 118 Pages
  • Global
From
Pigmentation Disorders Treatment Market - Global Industry Size, Share, Trends Opportunity, and Forecast, 2028F - Product Image

Pigmentation Disorders Treatment Market - Global Industry Size, Share, Trends Opportunity, and Forecast, 2028F

  • Report
  • 178 Pages
  • Global
From
Global Pigmentation Disorders Treatment Market by Indication (Hyperpigmentation, Hypopigmentation), Treatment & Therapies (Chemical Peels, Dermabrasion, Laser Resurfacing), End User - Forecast 2024-2030 - Product Image

Global Pigmentation Disorders Treatment Market by Indication (Hyperpigmentation, Hypopigmentation), Treatment & Therapies (Chemical Peels, Dermabrasion, Laser Resurfacing), End User - Forecast 2024-2030

  • Report
  • 183 Pages
  • Global
From
Pigmentation Disorder Treatment Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Pigmentation Disorder Treatment Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 87 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.